Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 381

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1A
Chunk 381
---
 cannot be certain that there is no invalidating prior art, of which it and the patent examiner were unaware during prosecution. For
the patents and patent applications that we have licensed, we may have limited or no right to participate in the defense of any licensed
patents against challenge by a third party. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we
would lose at least part, and perhaps all, of any future patent protection on our current or future product candidates. Such a loss of
patent protection could harm our business. Additionally, any adverse outcome could allow third parties to commercialize our products and
compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing
third-party patent rights.

Even if we establish infringement, the court may decide not to grant
an injunction against further infringing activity and instead award only monetary damages, which may or may not be an adequate remedy.
We may not be able to detect or prevent, alone or with our licensors, misappropriation of our intellectual property rights, particularly
in countries where the laws may not protect those rights as fully as in the United States. Any litigation or other proceedings to
enforce our intellectual property rights may fail, and even if successful, may result in substantial costs and distract our management
and other employees.

73

Furthermore, because of the substantial amount of discovery required
in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by
disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions or other interim
proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have an adverse effect
on the price of our common shares.

We may not have sufficient financial or other resources to adequately
conduct such litigation or proceedings. Some of our competitors or other third parties may be able to sustain the costs of such litigation
or proceedings more effectively than we can because of their greater financial resources and more mature and developed intellectual property
portfolios. Because of the expense and uncertainty of litigation, we may conclude that even if a third party is infringing our issued
patent, any patents that may be issued as a result of our pending or future patent applications or other intellectual property rights,
the risk-adjusted cost of bringing and enforcing such a claim or action may be too high or not in the